Tower Research Capital (TRC)’s Cingulate CING Stock Holding History
Bought
Maintained
Sold
Other funds holding CING
CPIG
KAS
BAM
Tower Research Capital (TRC)'s CING Position: Q2 2026 in Review
Tower Research Capital (TRC) reduced its Cingulate (CING) stake by 11% in Q2 2026, selling an estimated $288 and leaving 474 shares worth $2.59K. The position accounts for ﹤0.01% of the portfolio, ranked #4639.
Tower Research Capital (TRC) first reported a position in CING in Q1 2022 and has held it in 17 quarters since. The position peaked at $12K in Q3 2022. 32 funds tracked by Wall St. Rank hold CING as of Q2 2026.
- Tower Research Capital (TRC) held 474 shares of Cingulate worth $2.59K as of Q2 2026.
- Tower Research Capital (TRC) sold 57 Cingulate shares in Q2 2026, an estimated $288.
- Cingulate made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4639 holding.
- Tower Research Capital (TRC) first reported a position in Cingulate in Q1 2022 and has held it in 17 quarters since.
- Tower Research Capital (TRC)'s Cingulate position peaked at $12K in Q3 2022.
- 32 funds tracked by Wall St. Rank held Cingulate as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.